Literature DB >> 23314724

Smoking and marijuana use in pregnancy.

Haywood L Brown1, Cornelia R Graves.   

Abstract

The obstetrical, neonatal, and childhood risk associated with prenatal smoking are well known. Prenatal smoking has been implicated in up to 25% of low birth weight infants primarily from preterm birth and fetal growth restriction and up to 10% of all infant mortality. The relationship between prenatal marijuana smoking and obstetrical and infant outcomes is less clear. Marijuana is the most commonly used illicit drug during pregnancy. Neither exposure to cigarette nor marijuana smoke has evidence for teratogenicity, but both have been implicated in developmental and hyperactivity disorders in children. Pregnant women should be counseled on the risk of both cigarette and marijuana smoking.

Entities:  

Mesh:

Year:  2013        PMID: 23314724     DOI: 10.1097/GRF.0b013e318282377d

Source DB:  PubMed          Journal:  Clin Obstet Gynecol        ISSN: 0009-9201            Impact factor:   2.190


  10 in total

1.  Association between marijuana use and adverse obstetrical and neonatal outcomes.

Authors:  C R Warshak; J Regan; B Moore; K Magner; S Kritzer; J Van Hook
Journal:  J Perinatol       Date:  2015-09-24       Impact factor: 2.521

2.  Effect of Tocopheryl Acetate on Maternal Cigarette Smoke Exposed Swiss Albino Mice Inbred Fetus.

Authors:  Janardan Chaudhary; Royana Singh; S N Shamal; K Supriya; Mona Srivastava; R S More
Journal:  J Clin Diagn Res       Date:  2016-10-01

3.  Urinary concentrations of PAH and VOC metabolites in marijuana users.

Authors:  Binnian Wei; K Udeni Alwis; Zheng Li; Lanqing Wang; Liza Valentin-Blasini; Connie S Sosnoff; Yang Xia; Kevin P Conway; Benjamin C Blount
Journal:  Environ Int       Date:  2015-12-12       Impact factor: 9.621

Review 4.  Caring for Women with Multiple Sclerosis Across the Lifespan.

Authors:  Kelsey Rankin; Riley Bove
Journal:  Curr Neurol Neurosci Rep       Date:  2018-05-23       Impact factor: 5.081

Review 5.  Adverse health effects of marijuana use.

Authors:  Nora D Volkow; Ruben D Baler; Wilson M Compton; Susan R B Weiss
Journal:  N Engl J Med       Date:  2014-06-05       Impact factor: 91.245

6.  Dose-dependent teratogenicity of the synthetic cannabinoid CP-55,940 in mice.

Authors:  Marcoita T Gilbert; Kathleen K Sulik; Eric W Fish; Lorinda K Baker; Deborah B Dehart; Scott E Parnell
Journal:  Neurotoxicol Teratol       Date:  2015-12-18       Impact factor: 3.763

7.  Marijuana use and maternal experiences of severe nausea during pregnancy in Hawai'i.

Authors:  Emily K Roberson; Walter K Patrick; Eric L Hurwitz
Journal:  Hawaii J Med Public Health       Date:  2014-09

8.  Cannabidiol changes P-gp and BCRP expression in trophoblast cell lines.

Authors:  Valeria Feinshtein; Offer Erez; Zvi Ben-Zvi; Noam Erez; Tamar Eshkoli; Boaz Sheizaf; Eyal Sheiner; Mahmud Huleihel; Gershon Holcberg
Journal:  PeerJ       Date:  2013-09-12       Impact factor: 2.984

9.  Social determinants and the classification of disease: descriptive epidemiology of selected socially mediated disease constellations.

Authors:  Robert S Levine; Barbara A Kilbourne; George S Rust; Michael A Langston; Baqar A Husaini; Lisaann S Gittner; Maureen Sanderson; Charles H Hennekens
Journal:  PLoS One       Date:  2014-11-05       Impact factor: 3.240

10.  Patterns of polydrug use among pregnant substance abusers.

Authors:  Therese Reitan
Journal:  Nordisk Alkohol Nark       Date:  2017-03-30
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.